PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
28-Feb-2023 mdgroup launches third fully compliant medical distribution centre in Europe mdgroup
27-Feb-2023 INDEPENDENT REVIEW INTO UK CLINICAL TRIALS CCRA
22-Feb-2023 Pharma Targeting Celebrates 10 years of Connecting People Intelligently Pharma Targeting
21-Feb-2023 Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories Almac Group
20-Feb-2023 Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona Phastar
17-Feb-2023 Understanding the Scope of Pharmacovigilance Courses TechnoBridge Systems
15-Feb-2023 The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Novotech Health Holdings Pte Ltd
10-Feb-2023 Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Novotech Health Holdings Pte Ltd
08-Feb-2023 ADVANCED CLINICAL NAMED 2023 BEST OF STAFFING® CLIENT AND TALENT AWARD WINNER Advanced Clinical
06-Feb-2023 RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies CluePoints
02-Feb-2023 AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials AARDEX Group
27-Jan-2023 Orchestra BioMed Debuts as Nasdaq-traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model Orchestra BioMed
26-Jan-2023 AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial AC Immune SA
26-Jan-2023 Cherwell publishes new guide to EM best practice in compliance with revised Annex 1 Cherwell Laboratories
26-Jan-2023 Future of clinical research in the NHS in jeopardy without urgent action, warns Lords Committee House of Lords
26-Jan-2023 Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast Almac Group
26-Jan-2023 New spray fights infections and antibiotic resistance The World Health Organization
26-Jan-2023 Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107 Douglas Pharmaceuticals
26-Jan-2023 ONXEO provides update on the Development Program for its first-in-class drug candidate AsiDNATM Onxeo
26-Jan-2023 Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease Orbsen Therapeutics Limited